Book Appointments & Health Checkup Packages
Book Appointments & Health Checkup Packages
Onco-Fertility Sparing Surgery is a specialised surgical approach aimed at removing cancerous tissue while preserving a woman's reproductive organs and fertility whenever possible. For women of childbearing age who hope to preserve their ability to become pregnant and have children in the future, this method is especially important.
Patients undergoing Onco-Fertility Sparing Surgery undergo a thorough evaluation by a multidisciplinary team of gynecologic oncologists, fertility specialists, and other healthcare providers. According to the patient's age, general health, cancer type and stage, and other variables, this assessment aids in determining whether fertility preservation options are feasible.
Onco-fertility Sparing Surgery Treatment in Dhakuria aims to remove cancerous tissue with the minimal risk of harm to the reproductive organs possible. This may involve techniques such as removing only the affected portion of the organ, rather than the entire organ or using minimally invasive surgical approaches to spare healthy tissue.
Onco-fertility Sparing Surgery is a type of medical procedure designed to treat cancer while preserving a patient's fertility. This means that doctors aim to remove the cancerous tissue while keeping the reproductive organs intact as much as possible, allowing patients the option to have children in the future.
The ideal candidates for Onco-fertility Sparing Surgery are women who:
Have been diagnosed with gynaecological cancer (cervical or ovarian cancer) at a young age or in their reproductive years.
Desire to preserve their fertility and have children in the future.
Have early-stage gynaecological cancer that is localised and has not spread to other parts of the body.
Possess tumours that are localised and small, making surgical removal possible without compromising the effectiveness of cancer treatment.
Onco-fertility Sparing Surgery is commonly used to treat gynaecological cancers such as cervical, ovarian, and uterine cancers. It can also be offered for various types of cancer, including epithelial ovarian cancer (EOC), borderline ovarian tumour (BOT), and non-epithelial ovarian cancer. However, its suitability depends on factors such as cancer type, stage, and individual patient circumstances.
A comprehensive evaluation by a multidisciplinary team, including oncologists, reproductive specialists, and surgeons, is essential. Factors considered include:
The type, stage, and location of your cancer.
Your age and overall health.
Your desire to preserve fertility and have children in the future.
The surgical approach varies depending on factors such as cancer type and stage. Common techniques include:
Partial Organ Resection: In some cases, only the affected portion of the organ containing the cancerous tissue may be removed, while the rest of the organ is preserved. For example, in cervical cancer, a procedure known as Radical Trachelectomy may be performed to remove the cervix while preserving the uterus, allowing for the possibility of future pregnancy.
Minimally Invasive Surgery: Whenever possible, surgeons may use minimally invasive techniques such as laparoscopy or robotic-assisted surgery to perform Onco-fertility Sparing procedures. These techniques involve making small incisions and using specialised instruments to access and remove the cancerous tissue while minimising damage to surrounding healthy tissue.
Tissue-Sparing Approaches: Surgeons may employ tissue-sparing approaches to minimise the impact of surgery on reproductive function. This may involve carefully dissecting tissue layers to preserve blood supply and nerve function to the reproductive organs, thereby reducing the risk of post-operative complications.
After removing the cancerous tissue, surgeons may perform reconstructive procedures to restore the anatomy and function of the reproductive organs. This may include techniques such as tissue grafting, suturing, or using synthetic materials to repair any defects created during surgery.
The primary benefit of Onco-fertility Sparing Surgery is that even after the cancer treatment, patients can maintain their ability to conceive and have children.
Minimally invasive procedures often result in quicker recovery times and less postoperative pain.
As with any surgery, there are risks associated with Onco-fertility Sparing Surgery, including:
Following surgery, there is a chance that cancer may recur, necessitating additional treatments such as Radiation Therapy or Chemotherapy.
Surgical complications such as infection, bleeding, or damage to nearby organs.
The possibility is that fertility may still be affected by cancer treatment.
Although recovery from Onco-fertility Sparing Surgery varies, it usually involves:
A hospital stay of a few days to monitor for complications.
A recovery period of a few weeks where activity is limited to allow healing.
Follow-up appointments to monitor your recovery and ensure the cancer has been effectively treated.
Yes, many patients are able to undergo fertility treatments such as In Vitro Fertilisation (IVF) after recovering from Fertility-sparing Surgery. Your healthcare team will discuss the best options for you based on your individual situation.
Patients may have access to options such as Embryo Cryopreservation, Egg Freezing, Ovarian Tissue Cryopreservation, or Hormonal Therapies to protect ovarian function during cancer treatment.
Home Dhakuria Specialities Gynaec-oncology Onco-fertility-sparing-surgery